+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asthma Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

  • ID: 5441874
  • Report
  • September 2021
  • Region: Global
  • 147 Pages
  • IMARC Group

FEATURED COMPANIES

  • Abbott
  • Amgen Inc.
  • AstraZeneca
  • Biogen Inc.
  • Boehringer Ingelheim GmbH
  • F. Hoffmann-La Roche AG
The global asthma therapeutics market reached a value of US$ 17.6 Billion in 2020. Looking forward, the market is expected to reach a value of US$ 19.13 Billion by 2026, expanding at a CAGR of 1.60% during 2021-2026. Keeping in mind the uncertainties of COVID-19, the analyst is continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Asthma therapeutics refer to various pharmaceutical drugs that are used for the treatment of asthma. Asthma is usually triggered by indoor and outdoor causative agents, including pollution, allergens and dust. These therapeutics are usually bronchodilators and anti-inflammatory drugs, which include corticosteroids, long-acting beta-agonists (LABA), methylxanthine, immunomodulators and leukotriene modifiers. A number of combination therapy drugs are also used that can be inhaled, injected, or orally administered. These drugs expand the passageway into the lungs and enable the movement of air to improve breathing. They also aid in clearing mucus from the lungs that gets coughed out with ease.

Global Asthma Therapeutics Market Trends and Drivers


The increasing prevalence of asthma and other respiratory disorders, along with improvements in the diagnostic technologies, is one of the key factors driving the growth of the market. Furthermore, rising awareness among the masses regarding the availability of effective asthma therapeutics is also providing driving the market growth. For instance, asthmatic patients are primarily treated with inhaled corticosteroids and patients with advanced conditions or persistent asthma are treated with target-specific drugs. There is also an extensive demand for monoclonal antibodies (mAbs) that block immunoglobulin E and specific cytokines. The development of combination therapies for the treatment of respiratory diseases is acting as another growth-inducing factor. Increasing healthcare expenditures, extensive research, and development (R&D) activities in the field of medical sciences and improvements in the healthcare infrastructure are some of the other factors that are expected to drive the market further.

Key Market Segmentation


The analyst provides an analysis of the key trends in each sub-segment of the global asthma therapeutics market, along with forecasts at the global, regional and country level from 2021-2026. The report has categorized the market based on drug class, product type, treatment type, route of administration and region.

Breakup by Drug Class

  • Anti-Inflammatory Drugs
  • Bronchodilators
  • Combination Therapies

Breakup by Product Type

  • Inhalers
  • Dry Powder Inhalers
  • Metered Dose Inhalers
  • Soft Mist Inhalers
  • Nebulizers
  • Pneumatic Nebulizers
  • Ultrasonic Nebulizers
  • Mesh Nebulizers

Breakup by Treatment Type

  • Quick-Relief Medications
  • Long-Term Asthma Control Medications

Breakup by Route of Administration

  • Inhalation
  • Oral
  • Parenteral

Breakup by Region

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape


The report has also analysed the competitive landscape of the market with some of the key players being AstraZeneca, Abbott, Amgen Inc., Biogen Inc., Boehringer Ingelheim GmbH, F. Hoffmann-La Roche AG, GlaxoSmithKline plc., Merck & Co. Inc., Novartis AG, Sunovion Pharmaceuticals Inc. (Dainippon Sumitomo Pharma Co. Ltd.) and Teva Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • Amgen Inc.
  • AstraZeneca
  • Biogen Inc.
  • Boehringer Ingelheim GmbH
  • F. Hoffmann-La Roche AG
1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Asthma Therapeutics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Drug Class
6.1 Anti-Inflammatory Drugs
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Bronchodilators
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Combination Therapies
6.3.1 Market Trends
6.3.2 Market Forecast

7 Market Breakup by Product Type
7.1 Inhalers
7.1.1 Market Trends
7.1.2 Major Types
7.1.2.1 Dry Powder Inhalers
7.1.2.2 Metered Dose Inhalers
7.1.2.3 Soft Mist Inhalers
7.1.3 Market Forecast
7.2 Nebulizers
7.2.1 Market Trends
7.2.2 Major Types
7.2.2.1 Pneumatic Nebulizers
7.2.2.2 Ultrasonic Nebulizers
7.2.2.3 Mesh Nebulizers
7.2.3 Market Forecast

8 Market Breakup by Treatment Type
8.1 Quick-Relief Medications
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Long-Term Asthma Control Medications
8.2.1 Market Trends
8.2.2 Market Forecast

9 Market Breakup by Route of Administration
9.1 Inhalation
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Oral
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Parenteral
9.3.1 Market Trends
9.3.2 Market Forecast

10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast

11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 AstraZeneca
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Abbott
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Amgen Inc.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Biogen Inc.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Boehringer Ingelheim GmbH
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 F. Hoffmann-La Roche AG
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 SWOT Analysis
15.3.7 GlaxoSmithKline PLC.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Merck & Co. Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Novartis AG
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Sunovion Pharmaceuticals Inc. (Dainippon Sumitomo Pharma Co. Ltd.)
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 SWOT Analysis
15.3.11 Teva Pharmaceutical Industries Ltd.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis



List of Figures
Figure 1: Global: Asthma Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Asthma Therapeutics Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Asthma Therapeutics Market: Breakup by Drug Class (in %), 2020
Figure 4: Global: Asthma Therapeutics Market: Breakup by Product Type (in %), 2020
Figure 5: Global: Asthma Therapeutics Market: Breakup by Treatment Type (in %), 2020
Figure 6: Global: Asthma Therapeutics Market: Breakup by Route of Administration (in %), 2020
Figure 7: Global: Asthma Therapeutics Market: Breakup by Region (in %), 2020
Figure 8: Global: Asthma Therapeutics Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 9: Global: Asthma Therapeutics (Anti-Inflammatory Drugs) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Global: Asthma Therapeutics (Anti-Inflammatory Drugs) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Global: Asthma Therapeutics (Bronchodilators) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Asthma Therapeutics (Bronchodilators) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Asthma Therapeutics (Combination Therapy) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Asthma Therapeutics (Combination Therapy) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Asthma Therapeutics (Inhalers) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Asthma Therapeutics (Inhalers) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Asthma Therapeutics (Nebulizers) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Asthma Therapeutics (Nebulizers) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Global: Asthma Therapeutics (Quick-Relief Medications) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Global: Asthma Therapeutics (Quick-Relief Medications) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Global: Asthma Therapeutics (Long-Term Asthma Control Medications) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Global: Asthma Therapeutics (Long-Term Asthma Control Medications) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Global: Asthma Therapeutics (Inhalation) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Global: Asthma Therapeutics (Inhalation) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Global: Asthma Therapeutics (Oral) Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Global: Asthma Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Global: Asthma Therapeutics (Parenteral) Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Global: Asthma Therapeutics (Parenteral) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: North America: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: North America: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: United States: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: United States: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Canada: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Canada: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Asia Pacific: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Asia Pacific: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: China: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: China: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: Japan: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: Japan: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: India: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: India: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: South Korea: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: South Korea: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: Australia: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: Australia: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: Indonesia: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: Indonesia: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: Others: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: Others: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: Europe: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: Europe: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: Germany: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: Germany: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: France: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: France: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: United Kingdom: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: United Kingdom: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: Italy: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: Italy: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: Spain: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: Spain: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: Russia: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 64: Russia: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 65: Others: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 66: Others: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 67: Latin America: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 68: Latin America: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 69: Brazil: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 70: Brazil: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 71: Mexico: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 72: Mexico: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 73: Others: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 74: Others: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 75: Middle East and Africa: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 76: Middle East and Africa: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 77: Global: Asthma Therapeutics Industry: SWOT Analysis
Figure 78: Global: Asthma Therapeutics Industry: Value Chain Analysis
Figure 79: Global: Asthma Therapeutics Industry: Porter’s Five Forces Analysis


List of Tables
Table 1: Global: Asthma Therapeutics Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Asthma Therapeutics Market Forecast: Breakup by Drug Class (in Million US$), 2021-2026
Table 3: Global: Asthma Therapeutics Market Forecast: Breakup by Product Type (in Million US$), 2021-2026
Table 4: Global: Asthma Therapeutics Market Forecast: Breakup by Treatment Type (in Million US$), 2021-2026
Table 5: Global: Asthma Therapeutics Market Forecast: Breakup by Route of Administration (in Million US$), 2021-2026
Table 6: Global: Asthma Therapeutics Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 7: Global: Asthma Therapeutics Market Structure
Table 8: Global: Asthma Therapeutics Market: Key Players
Note: Product cover images may vary from those shown
  • AstraZeneca
  • Abbott
  • Amgen Inc.
  • Biogen Inc.
  • Boehringer Ingelheim GmbH
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline PLC
  • Merck & Co. Inc.
  • Novartis AG
  • Sunovion Pharmaceuticals Inc. (Dainippon Sumitomo Pharma Co. Ltd.)
  • Teva Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown

Loading
LOADING...